In a free society, individuals should be free to care for their physical well-being as they see fit, which includes the freedom to choose the medical treatments they think best. Such liberty does not open the door for fraud or abuse any more than does a free market in other products. In fact, informed consent by patients will become more sophisticated as the market for information about medical treatments becomes more free and open.

More on FDA and Drug Regulation

Commentary

Wrong: Cheap Canadian Drugs Won’t Heighten Opioid Crisis

By Jeffrey Miron. American Conservative. June 26, 2017.

Senator Manchin’s Latest Attempt at Curbing Opioid Addiction Is a Very Bad Idea

By Jeffrey A. Singer. Huffington Post. May 24, 2017.

Marijuana Policy Is Best Left up to the States

By Michael D. Tanner. National Review (Online). March 1, 2017.

Cato Studies

With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths

By Daniel I. Rees, Joseph J. Sabia, Laura Argys, Joshua Latshaw, & Dhaval Dave. Research Briefs in Economic Policy No. 78. June 14, 2017.

Avoiding Medicare’s Pharmaceutical Trap

By Doug Bandow. Policy Analysis No. 556. November 30, 2005.

Treating Doctors as Drug Dealers: The DEA’s War on Prescription Painkillers

By Ronald T. Libby. Policy Analysis No. 545. June 6, 2005.

Articles

A Deadly Grip: Wisconsin’s Opioid Scourge: Its Origins and Possible Solutions

Ike Brannon and Devorah Goldman. Wisconsin Interest. Spring 2017.

Public Filings

Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. South Carolina

By Pratik A. Shah, Matthew A. Scarola, Hyland Hunt, Ilya Shapiro, & Randal John Meyer. Legal Briefs. December 9, 2015.

POM Wonderful, LLC v. FTC

By Jonathan W. Emord, Peter Arhangelsky, Eric Awerbuch, & Ilya Shapiro. Legal Briefs. November 23, 2015.

United States v. DeCoster

By Matthew G. Kaiser, Patrick N. Forrest, Ilya Shapiro, & Randal John Meyer. Legal Briefs. July 27, 2015.

Cato Reviews & Journals

Legislating Drug Price Transparency

Thomas A. Hemphill. Regulation. Summer 2017.

Should Government Subsidize and Regulate Electronic Health Records?

Michael L. Marlow. Regulation. Summer 2017.

Protecting Free Speech in Medicine

Christina Sandefur. Regulation. Summer 2017.

Events

The Kidney Sellers: A Journey of Discovery in Iran

Featuring Michael D. Tanner. March 26, 2014. Book Forum.

Drug Reimportation: The Free-Market Solution

Featuring . September 20, 2004. Capitol Hill Briefing.

Resolved: Congress Should Remove the Ban on Drug Reimportation

Featuring Roger Pilon. March 30, 2004. Policy Forum.